Home › Research › Brain scans and imaging
APOE ɛ4 dose associates with increased brain iron and β-amyloid via blood-brain barrier dysfunction
Uchida Y, Kan H, Sakurai K, Horimoto Y, Hayashi E, Iida A, Okamura N, Oishi K et al.. Journal of neurology, neurosurgery, and psychiatry, 2022-04-28
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Objective To examine the effect of apolipoprotein E ( APOE ) ɛ4 dose on blood-brain barrier (BBB) clearance function, evaluated using an advanced MRI technique and analyse its correlation with brain iron and β-amyloid accumulation in the early stages of the Alzheimer's continuum. Methods In this single-centre observational prospective cohort study, 24 APOE ɛ4 non-carriers, 22 heterozygotes and 20 homozygotes in the early stages of the Alzheimer's continuum were scanned with diffusion-prepared arterial spin labelling, which estimates the water exchange rate across the BBB (k w ). Participants also underwent quantitative susceptibility mapping, [ 11 C]Pittsburgh compound B-positron emission tomography and neuropsychological testing. Using an atlas-based approach, we compared the regional k w of the whole brain among the groups and analysed its correlation with the neuroradiological and neuropsychological findings. Results The BBB k w values in the neocortices differed significantly among the groups ( APOE ɛ4 non-carriers>heterozygotes>homozygotes). These values correlated with brain iron levels (frontal lobe: r =-0.476, 95% CI=-0.644 to -0.264, p=0.011; medial temporal lobe: r =-0.455, 95% CI=-0.628 to -0.239, p=0.017), β-amyloid loads (frontal lobe: r =-0.504, 95% CI=-0.731 to -0.176, p=0.015; medial temporal lobe: r =-0.452, 95% CI=-0.699 to -0.110, p=0.036) and neuropsychological scores, after adjusting for age, sex and APOE ɛ4 dose. Interpretation Our results suggest that an increased APOE ɛ4 dose is associated with decreased effective brain-waste clearance, such as iron and β-amyloid, through the BBB.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Uchida, Y., Kan, H., Sakurai, K., Horimoto, Y., Hayashi, E., Iida, A., et al. (2022). APOE ɛ4 dose associates with increased brain iron and β-amyloid via blood-brain barrier dysfunction. Journal of neurology, neurosurgery, and psychiatry. https://doi.org/10.1136/jnnp-2021-328519
Vancouver
Uchida Y, Kan H, Sakurai K, Horimoto Y, Hayashi E, Iida A, et al. APOE ɛ4 dose associates with increased brain iron and β-amyloid via blood-brain barrier dysfunction. Journal of neurology, neurosurgery, and psychiatry. 2022. doi:10.1136/jnnp-2021-328519. PMID: 35483916.
BibTeX
@article{uchida2022-35483916,
author = {Uchida, Y. and Kan, H. and Sakurai, K. and Horimoto, Y. and Hayashi, E. and Iida, A. and Okamura, N. and Oishi, K. and others},
title = {{APOE ɛ4 dose associates with increased brain iron and β-amyloid via blood-brain barrier dysfunction}},
journal = {Journal of neurology, neurosurgery, and psychiatry},
year = {2022},
doi = {10.1136/jnnp-2021-328519},
pmid = {35483916},
url = {https://doi.org/10.1136/jnnp-2021-328519}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Results The BBB k w values in the neocortices differed significantly among the groups ( APOE ɛ4 non-carriers>heterozygotes>homozygotes).
- Interpretation Our results suggest that an increased APOE ɛ4 dose is associated with decreased effective brain-waste clearance, such as iron and β-amyloid, through the BBB.
New to this subject? Start with our plain-English guide: Brain scans & tests →
Study details
- Study designcohort study
- Evidence strengthModerate
How this study scored 55/100
Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 32 of the 58 points we could judge it on, which is 55 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of neurology, neurosurgery, and psychiatry) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2022 — within 6 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 35483916) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 32 / 58 | Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 32 of the 58 points we could judge it on is 55 out of 100. |
| Total | 55 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Brain scans and imaging from nearby years
Also tagged “barrier-dysfunction”
2 studies in the library carry the topic tag “barrier-dysfunction”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 2 tagged studies.